Capecitabine

Product Name : Capecitabine

CAS : 154361-50-9

Molecular Formula : C15H22FN3O6

Molecular Weight : 359.35 g/mol

Pharmaceutical Grade :

Therapeutic Category : Antimetabolites

team

Global Calcium is one of the leading manufacturers and exporters of Capecitabine CAS no. 154361-50-9, API, (Active Pharmaceutical Ingredient). We support the customers with exhaustive documentation. As a USDMF & EU-GMP certified global company and an established hallmark for pharmaceutical standards, Global Calcium has stood the test of time since its inception in 1979.

As manufacturer of Capecitabine we hereby state the following facts about the drug:

Capecitabine is an oral chemotherapy medication used to treat breast cancer, colorectal cancer, and other cancers. It is a prodrug of 5-fluorouracil (5-FU), which is a pyrimidine analog that interferes with DNA synthesis. Capecitabine is converted to 5-FU in the liver, and it then works by blocking the growth of cancer cells.

Capecitabine is indicated as treatment for a variety of cancer types. For colorectal cancer, capecitabine is indicated as a single agent or a component of a combination chemotherapy regiment for the adjuvant treatment of stage III colon cancer and treatment unresectable or metastatic colorectal cancer. It can also be used as a part of a combination chemotherapy perioperative treatment of adult locally advanced rectal cancer. For breast cancer, capecitabine is indicated for advanced or metastatic breast cancer as a single agent if an anthracycline- or taxane-containing chemotherapy is not indicated or as a regimen with docetaxel after disease progression on prior anthracycline-containing chemotherapy. For gastric, esophageal, or gastroesophageal junction (GEJ) cancer, capecitabine is indicated as a component of a combination chemotherapy treatment for the treatment of adult unresectable or metastatic gastric, esophageal, or GEJ cancer or adult HER2-overexpressing metastatic gastric or GEJ adenocarcinoma who have not received prior treatment for metastatic disease. Finally, for pancreatic cancer, capecitabine is indicated as adjuvant treatment for adult pancreatic adenocarcinoma as a component of a combination chemotherapy regimen.

 

Global Calcium is a leading manufacturer of this drug. We manufacture this pharmaceutical drug and make it available to domestic and overseas market